HISTAFED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Histafed, and what generic alternatives are available?
Histafed is a drug marketed by Cenci and is included in one NDA.
The generic ingredient in HISTAFED is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HISTAFED?
- What are the global sales for HISTAFED?
- What is Average Wholesale Price for HISTAFED?
Summary for HISTAFED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 5,256 |
| DailyMed Link: | HISTAFED at DailyMed |
US Patents and Regulatory Information for HISTAFED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cenci | HISTAFED | pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 088283-001 | Apr 20, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
